These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 7571641)

  • 21. Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis.
    Aizer A; Stern EH; Gomes JA; Teirstein AS; Eckart RE; Mehta D
    Am J Cardiol; 2005 Jul; 96(2):276-82. PubMed ID: 16018857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of ventricular arrhythmia burden, therapeutic interventions, and survival, in patients < 75 and patients >or= 75 years of age treated with implantable cardioverter defibrillators.
    Ermis C; Zhu AX; Vanheel L; Sakaguchi RN; Lurie KG; Lu F; Benditt DG
    Europace; 2007 May; 9(5):270-4. PubMed ID: 17371804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Roguin A; Bomma CS; Nasir K; Tandri H; Tichnell C; James C; Rutberg J; Crosson J; Spevak PJ; Berger RD; Halperin HR; Calkins H
    J Am Coll Cardiol; 2004 May; 43(10):1843-52. PubMed ID: 15145110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].
    Marín F; Gimeno JR; Payá E; García-Alberola A; Pérez-Alvarez L; Fernández X; de la Morena G; Sogorb F; Castro-Beiras A; Valdés M; Martínez JG; Monserrat L
    Rev Esp Cardiol; 2006 Jun; 59(6):537-44. PubMed ID: 16790196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implantable cardioverter-defibrillators in end-stage heart failure patients listed for heart transplantation: Results from a large retrospective registry.
    Gandjbakhch E; Rovani M; Varnous S; Maupain C; Chastre T; Waintraub X; Pousset F; Lebreton G; Duthoit G; Badenco N; Himbert C; Leprince P; Hidden-Lucet F
    Arch Cardiovasc Dis; 2016; 109(8-9):476-85. PubMed ID: 27344378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of all-cause mortality for patients with chronic Chagas' heart disease receiving implantable cardioverter defibrillator therapy.
    Cardinalli-Neto A; Bestetti RB; Cordeiro JA; Rodrigues VC
    J Cardiovasc Electrophysiol; 2007 Dec; 18(12):1236-40. PubMed ID: 17900257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator.
    Moss AJ; Greenberg H; Case RB; Zareba W; Hall WJ; Brown MW; Daubert JP; McNitt S; Andrews ML; Elkin AD;
    Circulation; 2004 Dec; 110(25):3760-5. PubMed ID: 15583079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias.
    Healey JS; Hallstrom AP; Kuck KH; Nair G; Schron EP; Roberts RS; Morillo CA; Connolly SJ
    Eur Heart J; 2007 Jul; 28(14):1746-9. PubMed ID: 17283003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age dependent efficacy of implantable cardioverter-defibrillator treatment: observations in 450 patients over an 11 year period.
    Trappe HJ; Pfitzner P; Achtelik M; Fieguth HG
    Heart; 1997 Oct; 78(4):364-70. PubMed ID: 9404252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outpatient inotropic therapy in heart transplant candidates: should its use influence waiting list priority status?
    Winkel E; Kao W; Fisher SG; Heroux AL; Johnson MR; Costanzo MR
    J Heart Lung Transplant; 1998 Aug; 17(8):809-16. PubMed ID: 9730431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?
    Ellenbogen KA; Levine JH; Berger RD; Daubert JP; Winters SL; Greenstein E; Shalaby A; Schaechter A; Subacius H; Kadish A;
    Circulation; 2006 Feb; 113(6):776-82. PubMed ID: 16461817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved survival of cardiac transplantation candidates with implantable cardioverter defibrillator therapy: role of beta-blocker or amiodarone treatment.
    Ermis C; Zadeii G; Zhu AX; Fabian W; Collins J; Lurie KG; Sakaguchi S; Benditt DG
    J Cardiovasc Electrophysiol; 2003 Jun; 14(6):578-83. PubMed ID: 12875416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of implantable cardioverter-defibrillators on mortality among patients on the waiting list for heart transplantation.
    Grimm M; Wieselthaler G; Avanessian R; Grimm G; Schmidinger H; Schreiner W; Podczeck A; Wolner E; Laufer G
    J Thorac Cardiovasc Surg; 1995 Aug; 110(2):532-9. PubMed ID: 7637372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The implantable cardioverter defibrillator as a "bridge to transplant": a viable clinical strategy?
    Schmidinger H
    Am J Cardiol; 1999 Mar; 83(5B):151D-157D. PubMed ID: 10089858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival benefit of the implantable cardioverter-defibrillator in patients on the waiting list for cardiac transplantation.
    Sandner SE; Wieselthaler G; Zuckermann A; Taghavi S; Schmidinger H; Pacher R; Ploner M; Laufer G; Wolner E; Grimm M
    Circulation; 2001 Sep; 104(12 Suppl 1):I171-6. PubMed ID: 11568051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary preventive cardioverter-defibrillator implantation (Pro-ICD) in patients awaiting heart transplantation. A prospective, randomized, controlled 12-year follow-up study.
    Pezawas T; Grimm M; Ristl R; Kivaranovic D; Moser FT; Laufer G; Schmidinger H
    Transpl Int; 2015 Jan; 28(1):34-41. PubMed ID: 25176271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early benefit of implantable cardioverter defibrillator therapy in patients waiting for cardiac transplantation.
    Lorga-Filho A; Geelen P; Vanderheyden M; Malacky T; Primo J; Goethals M; Wellens F; Brugada P
    Pacing Clin Electrophysiol; 1998 Sep; 21(9):1747-50. PubMed ID: 9744438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence and clinical significance of multiple consecutive, appropriate, high-energy discharges in patients with implanted cardioverter-defibrillators.
    Villacastín J; Almendral J; Arenal A; Albertos J; Ormaetxe J; Peinado R; Bueno H; Merino JL; Pastor A; Medina O; Tercedor L; Jiménez F; Delcán JL
    Circulation; 1996 Feb; 93(4):753-62. PubMed ID: 8641005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychological vulnerability, ventricular tachyarrhythmias and mortality in implantable cardioverter defibrillator patients: is there a link?
    Pedersen SS; Brouwers C; Versteeg H
    Expert Rev Med Devices; 2012 Jul; 9(4):377-88. PubMed ID: 22905842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adult candidates for heart transplantation with larger body surface area have better prognosis on waiting list after progression to critically ill status.
    Komoda T; Drews T; Hetzer R; Lehmkuhl HB
    Eur J Cardiothorac Surg; 2011 Mar; 39(3):317-22. PubMed ID: 20884220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.